Reproducibility of the WHO histological criteria for the diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasms

[1]  T. Barbui,et al.  Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis). , 2012, Blood.

[2]  S. Bosari,et al.  The European Consensus on grading of bone marrow fibrosis allows a better prognostication of patients with primary myelofibrosis , 2012, Modern Pathology.

[3]  M. Cazzola,et al.  A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment. , 2012, Blood.

[4]  T. Barbui,et al.  Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early/prefibrotic primary myelofibrosis. , 2012, Blood.

[5]  J. D. van der Walt,et al.  European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis , 2012, Haematologica.

[6]  K. Hebeda,et al.  Reproducibility of histologic classification in nonfibrotic myeloproliferative neoplasia. , 2011, American journal of clinical pathology.

[7]  T. Barbui,et al.  Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  E. Parot-Schinkel,et al.  Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis , 2010, Histopathology.

[9]  C. Bloomfield,et al.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. , 2009, Blood.

[10]  A. Zanella,et al.  The significance of bone marrow biopsy and JAK2V617F mutation in the differential diagnosis between the "early" prepolycythemic phase of polycythemia vera and essential thrombocythemia. , 2008, American journal of clinical pathology.

[11]  U. Gianelli,et al.  Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis. , 2008, Blood.

[12]  C. Bloomfield,et al.  Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. , 2007, Blood.

[13]  Alessia Moro,et al.  Essential thrombocythemia or chronic idiopathic myelofibrosis? A single-center study based on hematopoieticbone marrow histology , 2006, Leukemia & lymphoma.

[14]  V. Diehl,et al.  Initial (Latent) Polycythemia vera with Thrombocytosis Mimicking Essential Thrombocythemia , 2005, Acta Haematologica.

[15]  H M Kvasnicka,et al.  Standardization of bone marrow features--does it work in hematopathology for histological discrimination of different disease patterns? , 2005, Histology and histopathology.

[16]  J. Thiele,et al.  Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients , 2003, Annals of Hematology.

[17]  V. Diehl,et al.  Initial (prefibrotic) stages of idiopathic (primary) myelofibrosis (IMF) – a clinicopathological study , 1999, Leukemia.

[18]  V. Diehl,et al.  Idiopathic primary osteo-myelofibrosis: a clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact. , 1996, Leukemia & lymphoma.

[19]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[20]  B. Everitt,et al.  Large sample standard errors of kappa and weighted kappa. , 1969 .

[21]  M. Hyman.  A necropsy tally board. , 1958, American journal of clinical pathology.

[22]  J. Ferro,et al.  Chronic myeloproliferative diseases. , 2014, Handbook of clinical neurology.

[23]  Peter J Campbell,et al.  Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes. , 2008, Blood.

[24]  J. D. van der Walt,et al.  European consensus on grading bone marrow fibrosis and assessment of cellularity. , 2005, Haematologica.

[25]  Ada Maria Florena,et al.  Value of bone marrow biopsy in the diagnosis of essential thrombocythemia. , 2004, Haematologica.

[26]  H M Kvasnicka,et al.  Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis. , 2000, Haematologica.